Bristol-Myers Squibb Company
CYCLIC DINUCLEOTIDES AS ANTICANCER AGENTS

Abstract:

The present invention is directed to compounds of the formulae I, II and III as shown below ##STR00001## wherein all substituents are defined herein, as well as pharmaceutically acceptable compositions comprising compounds of the invention and methods of using said compositions in the treatment of various disorders.